Adults with cystic fibrosis experience higher pain prevalence and severity compared to healthy controls, with significant unmet needs in pain management. New study highlights critical gaps in care.

Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and often fatal lung disease characterized by the scarring (fibrosis) of lung tissue, ...

When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...

Robert F. Kennedy Jr., Trump’s pick for health secretary, sought to use Samoa’s measles vaccine pause as a "natural ...

Virtual choir program founder Ashley Ballou-Bonnema shares her selfless story on living with and advocating for a life with the chronic disease.

SP-101 is under clinical development by Spirovant Sciences and currently in Phase II for Cystic Fibrosis. According to GlobalData, Phase II drugs for Cystic Fibrosis have a 31% phase transition ...

This complaint underscores the severe shortcomings of the Cuban healthcare system and the desperation families ... underlying defect in certain CFTR gene mutations causing cystic fibrosis. Respiratory ...

In December, the FDA approved Vertex’s vanzacaftor, tezacaftor and deutivacaftor (Alyftrek) for the treatment of cystic fibrosis in ... reported in The Lancet Respiratory Medicine in January.

Ivacaftor Oral Granules, 25 mg, 50 mg and 75 mg per unit dose packet are indicated for cystic fibrosis ... including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, ...

They help manage respiratory symptoms and provide ... are doctors who specialize in the digestive system and play a vital role in managing cystic fibrosis care. The pancreas and intestines can ...

Cystic fibrosis is a genetic disorder that affects various organs, including the lungs and digestive system. Medications are important for managing symptoms, but there is currently no cure for the ...